SCHEMBL10339766

SCHEMBL10339766

COc1ccc(-c2cc(=O)n(C)c(=O)[nH]2)cc1OC

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 5/20 0.57
▸ ALDH1A1 P00352 4/20 0.57
▸ MAPT P10636 3/20 0.57
▸ SMN1; SMN2 Q16637 2/20 0.57
▸ THRB P10828 2/20 0.53
▸ KDM4C Q9H3R0 1/20 0.49
▸ NPC1 O15118 1/20 0.46
▸ ADORA2B P29275 1/20 0.45
▸ MEN1 O00255 2/20 0.43
▸ GAA P10253 2/20 0.43
▸ KMT2A Q03164 2/20 0.43
▸ HPGD P15428 1/20 0.43
▸ TDP1 Q9NUW8 1/20 0.43
▸ PDE4A P27815 2/20 0.43
▸ PDE4B Q07343 2/20 0.43
▸ PDE4C Q08493 2/20 0.43
▸ PDE4D Q08499 2/20 0.43
▸ PDE3B Q13370 1/20 0.43
▸ PDE3A Q14432 1/20 0.43
▸ CYP19A1 P11511 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10565006 0.85 ALDH1A1 (0.55) KDM4EALDH1A1MAPTSMN1; SMN2THRB
SCHEMBL10566516 0.81 ALDH1A1 (0.53) KDM4EALDH1A1MAPTSMN1; SMN2THRB
SCHEMBL10565535 0.77 KDM4E (0.52) KDM4EALDH1A1MAPTSMN1; SMN2THRB
SCHEMBL10564671 0.76 MAPT (0.57) KDM4EALDH1A1MAPTSMN1; SMN2THRB
SCHEMBL10566796 0.76 MAPT (0.57) KDM4EALDH1A1MAPTSMN1; SMN2THRB
SCHEMBL12953800 0.74 KDM4E (0.48) KDM4EALDH1A1MAPTSMN1; SMN2THRB
SCHEMBL10568592 0.74 KDM4E (0.46) KDM4EALDH1A1MAPTSMN1; SMN2THRB
SCHEMBL10569385 0.73 KDM4E (0.66) KDM4EALDH1A1MAPTSMN1; SMN2THRB
SCHEMBL15657910 0.72 KDM4E (0.46) KDM4EALDH1A1MAPTSMN1; SMN2THRB
SCHEMBL10568294 0.72 TSHR (0.50) KDM4EALDH1A1MAPTTHRBKDM4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2256669-A — — None — — JP disclosed
JP-H02256669-A PRODUCTION OF PYRIMIDINONE COMPOUND FUJISAWA PHARMACEUT CO LTD 1990-10-17 — — JP disclosed
US-4824851-A Pyrimidones as cardiotonic, anti hypertensive, cerebrovascular vasodilator and anti-platelet agents FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1989-04-25 — — US disclosed
EP-0123402-B1 PYRIMIDINE DERIVATIVES, PREPARATION THEREOF AND USE THEREOF FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1988-09-07 — — EP disclosed
US-4746664-A Substituted-3,4-dihydro-4-(2,4,6-trimethoxyphenylimino)-2(1H)-pyrimidones useful as cardiotonic, antihypertensive, cerebrovascular vasodilator and anti-platelet agent FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1988-05-24 — — US disclosed
US-4612376-A Substituted-3,4-dihydro-4-(2,4,6-trimethoxyphenylimino)-2(1H)-pyrimidones useful as cardiotonic, antihypertensive, cerebrovascular vasodilator and anti-platelet agent FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1986-09-16 — — US disclosed
EP-0123402-A2 Pyrimidine derivatives, preparation thereof and use thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1984-10-31 — — EP disclosed
Send feedback